Literature DB >> 24846514

Cardiac implantable electronic device lead extraction in patients with underlying infection using open thoracotomy or percutaneous techniques.

Divyang Patel, Faris Khan, Hemal Shah, Sanjoy Bhattacharya, Evan Adelstein, Samir Saba1.   

Abstract

BACKGROUND: Explanting infected cardiac implantable electronic devices (CIEDs) and extracting their associated leads can be performed percutaneously (EP) or via open-thoracotomy (OR) approach. In this study, we examined the characteristics and outcomes of infected CIED patients undergoing EP vs. OR extraction procedures.
METHODS: All patients (EP: n = 329 and OR: n = 24) who received lead extraction in the presence of an infected CIED from 2005 to 2010 at the University of Pittsburgh Medical Center were included in this study. Demographic and clinical characteristics were obtained from the electronic medical records. The Charlson comorbidity index (CCI) was used to adjust for severity of co-morbid conditions.
RESULTS: Compared to the EP group, OR patients were more likely to have positive blood cultures, larger vegetations, and worse CCI scores. They also had higher total mortality rates at 1 (p = 0.036), 6 (p = 0.020), and 12 months (p = 0.012) after the procedure. One-year survival after lead extractions was significantly better for the EP compared to the OR group (p = 0.002) even after adjusting for other comorbid illnesses (HR = 2.6, p = 0.010) in a Cox regression model.
CONCLUSIONS: Infected CIED patients undergoing open-chest lead extraction are sicker and have higher mortality rates compared to those undergoing percutaneous extraction. Randomized, prospective data are needed to determine whether the procedural strategy for lead extraction accounts in part for the difference in outcome.

Entities:  

Mesh:

Year:  2014        PMID: 24846514     DOI: 10.5603/CJ.a2014.0038

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  3 in total

1.  European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Carina Blomström-Lundqvist; Vassil Traykov; Paola Anna Erba; Haran Burri; Jens Cosedis Nielsen; Maria Grazia Bongiorni; Jeanne Poole; Giuseppe Boriani; Roberto Costa; Jean-Claude Deharo; Laurence M Epstein; Laszlo Saghy; Ulrika Snygg-Martin; Christoph Starck; Carlo Tascini; Neil Strathmore
Journal:  Europace       Date:  2020-04-01       Impact factor: 5.214

Review 2.  New Insights in Central Venous Disorders. The Role of Transvenous Lead Extractions.

Authors:  Giulia Domenichini; Mathieu Le Bloa; Patrice Carroz; Denis Graf; Claudia Herrera-Siklody; Cheryl Teres; Alessandra Pia Porretta; Patrizio Pascale; Etienne Pruvot
Journal:  Front Cardiovasc Med       Date:  2022-02-23

3.  Transvenous lead extraction: Can it be simple yet safe?

Authors:  Antonios P Antoniadis; Vassilios P Vassilikos
Journal:  Anatol J Cardiol       Date:  2017-10       Impact factor: 1.596

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.